New strategies for effective treatment of vitamin K antagonist-associated bleeding

Area of Science:

• Pharmacology
• Internal Medicine
• Hematology

Background:

• Vitamin K antagonists (VKAs) have been mainstays in preventing thromboembolic events for decades.
• Direct oral anticoagulants (DOACs) offer alternatives but VKAs remain crucial for specific conditions.
• Severe bleeding is a significant risk requiring prompt reversal strategies.

Purpose of the Study:

• To review current evidence on managing severe bleeding in patients on vitamin K antagonists.
• To provide physicians with effective treatment strategies for VKA-associated bleeding.

Main Methods:

• Review of current evidence on VKA reversal agents.
• Analysis of treatment strategies for VKA-associated bleeding.

Main Results:

• Several options exist for reversing vitamin K antagonists, including vitamin K, prothrombin complex concentrates, and plasma.
• Effective management strategies are crucial for VKA-associated bleeding.

Conclusions:

• Despite advancements in anticoagulation, vitamin K antagonists are still widely used.
• Physicians need clear guidance on managing severe bleeding complications associated with VKAs.